Importantly, serum LOXL2 level has an excellent capacity to distinguish HCC from non-HCC patients, as evidenced by the area under the receiver operating characteristic (ROC) standing at 0.896 [42]. Here, LOXL2 is linked to hepatocellular carcinoma.